3-(4,4-dimethylpiperazin-4-ium-1-yl)-1-methyl-5-propan-2-ylindazole;1-methyl-3-(4-methylpiperazin-1-yl)-5-propan-2-ylpyrazolo[4,3-b]pyridine;1-methyl-5-[(2S)-1-methyl-4-propan-2-ylpiperazin-2-yl]indazole;1-methyl-5-[(2R)-1-methyl-4-propan-2-ylpiperazin-2-yl]indazole;5-methyl-3-(4-propan-2-yl-2-pyridinyl)-7H-cyclopenta[b]pyridine;1-methyl-5-propan-2-yl-3-pyridin-3-ylpyrazolo[4,3-b]pyridine;1-methyl-5-propan-2-yl-3-pyrimidin-5-ylindazole;1-methyl-5-propan-2-yl-3-[4-(1,1,1-trifluoropropan-2-yl)piperazin-1-yl]indazole
C129H173F3N31+ — CID 159981040
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(4,4-dimethylpiperazin-4-ium-1-yl)-1-methyl-5-propan-2-ylindazole;1-methyl-3-(4-methylpiperazin-1-yl)-5-propan-2-ylpyrazolo[4,3-b]pyridine;1-methyl-5-[(2S)-1-methyl-4-propan-2-ylpiperazin-2-yl]indazole;1-methyl-5-[(2R)-1-methyl-4-propan-2-ylpiperazin-2-yl]indazole;5-methyl-3-(4-propan-2-yl-2-pyridinyl)-7H-cyclopenta[b]pyridine;1-methyl-5-propan-2-yl-3-pyridin-3-ylpyrazolo[4,3-b]pyridine;1-methyl-5-propan-2-yl-3-pyrimidin-5-ylindazole;1-methyl-5-propan-2-yl-3-[4-(1,1,1-trifluoropropan-2-yl)piperazin-1-yl]indazole
3-(4,4-dimethylpiperazin-4-ium-1-yl)-1-methyl-5-propan-2-ylindazole;1-methyl-3-(4-methylpiperazin-1-yl)-5-propan-2-ylpyrazolo[4,3-b]pyridine;1-methyl-5-[(2S)-1-methyl-4-propan-2-ylpiperazin-2-yl]indazole;1-methyl-5-[(2R)-1-methyl-4-propan-2-ylpiperazin-2-yl]indazole;5-methyl-3-(4-propan-2-yl-2-pyridinyl)-7H-cyclopenta[b]pyridine;1-methyl-5-propan-2-yl-3-pyridin-3-ylpyrazolo[4,3-b]pyridine;1-methyl-5-propan-2-yl-3-pyrimidin-5-ylindazole;1-methyl-5-propan-2-yl-3-[4-(1,1,1-trifluoropropan-2-yl)piperazin-1-yl]indazole (PubChem CID 159981040) has the molecular formula C129H173F3N31+ and a molecular weight of 2215.01 g/mol. Its IUPAC name is 3-(4,4-dimethylpiperazin-4-ium-1-yl)-1-methyl-5-propan-2-ylindazole;1-methyl-3-(4-methylpiperazin-1-yl)-5-propan-2-ylpyrazolo[4,3-b]pyridine;1-methyl-5-[(2S)-1-methyl-4-propan-2-ylpiperazin-2-yl]indazole;1-methyl-5-[(2R)-1-methyl-4-propan-2-ylpiperazin-2-yl]indazole;5-methyl-3-(4-propan-2-yl-2-pyridinyl)-7H-cyclopenta[b]pyridine;1-methyl-5-propan-2-yl-3-pyridin-3-ylpyrazolo[4,3-b]pyridine;1-methyl-5-propan-2-yl-3-pyrimidin-5-ylindazole;1-methyl-5-propan-2-yl-3-[4-(1,1,1-trifluoropropan-2-yl)piperazin-1-yl]indazole.
Molecular Properties
| Compound Name | 3-(4,4-dimethylpiperazin-4-ium-1-yl)-1-methyl-5-propan-2-ylindazole;1-methyl-3-(4-methylpiperazin-1-yl)-5-propan-2-ylpyrazolo[4,3-b]pyridine;1-methyl-5-[(2S)-1-methyl-4-propan-2-ylpiperazin-2-yl]indazole;1-methyl-5-[(2R)-1-methyl-4-propan-2-ylpiperazin-2-yl]indazole;5-methyl-3-(4-propan-2-yl-2-pyridinyl)-7H-cyclopenta[b]pyridine;1-methyl-5-propan-2-yl-3-pyridin-3-ylpyrazolo[4,3-b]pyridine;1-methyl-5-propan-2-yl-3-pyrimidin-5-ylindazole;1-methyl-5-propan-2-yl-3-[4-(1,1,1-trifluoropropan-2-yl)piperazin-1-yl]indazole |
|---|---|
| PubChem CID | 159981040 |
| Molecular Formula | C129H173F3N31+ |
| Molecular Weight | 2215.01 g/mol |
| Exact Mass | 2213.44 |
| IUPAC Name | 3-(4,4-dimethylpiperazin-4-ium-1-yl)-1-methyl-5-propan-2-ylindazole;1-methyl-3-(4-methylpiperazin-1-yl)-5-propan-2-ylpyrazolo[4,3-b]pyridine;1-methyl-5-[(2S)-1-methyl-4-propan-2-ylpiperazin-2-yl]indazole;1-methyl-5-[(2R)-1-methyl-4-propan-2-ylpiperazin-2-yl]indazole;5-methyl-3-(4-propan-2-yl-2-pyridinyl)-7H-cyclopenta[b]pyridine;1-methyl-5-propan-2-yl-3-pyridin-3-ylpyrazolo[4,3-b]pyridine;1-methyl-5-propan-2-yl-3-pyrimidin-5-ylindazole;1-methyl-5-propan-2-yl-3-[4-(1,1,1-trifluoropropan-2-yl)piperazin-1-yl]indazole |
| SMILES | CC(C)N1CCN(C)[C@@H](c2ccc3c(cnn3C)c2)C1.CC(C)N1CCN(C)[C@H](c2ccc3c(cnn3C)c2)C1.CC(C)c1ccc2c(c1)c(-c1cncnc1)nn2C.CC(C)c1ccc2c(c1)c(N1CCN(C(C)C(F)(F)F)CC1)nn2C.CC(C)c1ccc2c(c1)c(N1CC[N+](C)(C)CC1)nn2C.CC(C)c1ccc2c(n1)c(-c1cccnc1)nn2C.CC(C)c1ccc2c(n1)c(N1CCN(C)CC1)nn2C.CC1=CCc2ncc(-c3cc(C(C)C)ccn3)cc21 |
| InChI | InChI=1S/C18H25F3N4.C17H27N4.C17H18N2.2C16H24N4.C15H23N5.2C15H16N4/c1-12(2)14-5-6-16-15(11-14)17(22-23(16)4)25-9-7-24(8-10-25)13(3)18(19,20)21;1-13(2)14-6-7-16-15(12-14)17(18-19(16)3)20-8-10-21(4,5)11-9-20;1-11(2)13-6-7-18-17(9-13)14-8-15-12(3)4-5-16(15)19-10-14;2*1-12(2)20-8-7-18(3)16(11-20)13-5-6-15-14(9-13)10-17-19(15)4;1-11(2)12-5-6-13-14(16-12)15(17-19(13)4)20-9-7-18(3)8-10-20;1-10(2)11-4-5-14-13(6-11)15(18-19(14)3)12-7-16-9-17-8-12;1-10(2)12-6-7-13-15(17-12)14(18-19(13)3)11-5-4-8-16-9-11/h5-6,11-13H,7-10H2,1-4H3;6-7,12-13H,8-11H2,1-5H3;4,6-11H,5H2,1-3H3;2*5-6,9-10,12,16H,7-8,11H2,1-4H3;5-6,11H,7-10H2,1-4H3;2*4-10H,1-3H3/q;+1;;;;;;/t;;;2*16-;;;/m...10.../s1 |
| InChIKey | OFTUERHBBCKSNH-ZYRIDPQQSA-N |
| XLogP | 23.28 |
| TPSA | 244.13 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 30 |
| Rotatable Bonds | 17 |
| Heavy Atoms | 163 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2215.01 |
| LogP ≤ 5 | 23.28 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 30 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159981040 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.